论文部分内容阅读
[目的]观察老年肺部感染临床诊治。[方法]62例病人用随机对照方法分为两组,分别使用头孢米诺和头孢唑肟,疗程10～14d,观察两种药物治疗中重度肺部感染的临床疗效及副反应的差别。[结果]头孢米诺组32例病人,临床有效率87.5%,头孢唑肟组30例病人,临床有效率80%。两组比较差异无统计学意义(P﹥0.05)。[结论]两药对常见的院外获得性肺部感染的病原菌有较好的抗菌效果,治疗中、重度肺部感染安全、有效,但两药对铜绿假单胞菌效果差.
[Objective] To observe the clinical diagnosis and treatment of senile pulmonary infection. [Methods] Sixty-two patients were divided into two groups by randomized control. Cefmetazole and ceftizoxime were used respectively for 10 ~ 14 days. The clinical efficacy and side effects of the two drugs in treating moderate-severe pulmonary infection were observed. [Results] 32 patients in the cefmenil group had a clinical effective rate of 87.5% and 30 patients in the ceftizoxime group had a clinical effective rate of 80%. There was no significant difference between the two groups (P> 0.05). [Conclusion] The two drugs have good antibacterial effect on the common pathogen of extra-nosocomial pulmonary infection. The treatment of moderate and severe pulmonary infections is safe and effective, but the two drugs are not effective against Pseudomonas aeruginosa.